Researchers continue to excited about this new drug, a groundbreaking dual treatment showing significant outcomes in clinical trials for size reduction . It works by targeting two systems: GLP-1 and GIP, which , when engaged , assist control cravings and enhance energy expenditure . Initial findings demonstrate noteworthy weight loss and possible b